Food and Drug Administration (FDA) for medical use
Sold for laboratory use only, it is not an approved drug and has no established human dose
At the Pernicious Anaemia Society we will continue addressing these challenges, to work towards ensuring better diagnosis, treatment, and overall, care for people with Pernicious Anaemia.
BPC-157 complements these effects through its enhancement of cellular proliferation and migrationincreasing fibroblast numbers at sites requiring matrix deposition while simultaneously upregulating MMP-2 by 85% to facilitate cellular movement through dense matrix environments, then stimulating TIMP production to prevent excessive proteolysis
Its important to select an agent that wont interfere with the stability or solubility of the peptide being reconstituted
Unlike anti-inflammatory drugs that can impair healing, TB500 reduces inflammation while still supporting repair